Yet, the molecular mechanism and interaction hotspot identification of caffeic acid as a dual inhibitor targeting DPP-4 and MMP-9 for T2DM and DFU treatment are still rarely discussed. The gene discussed is MMP9; the disease is type 2 diabetes mellitus.